Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003433.pdf 0001562180-19-003433.rtf View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003440.pdf 0001562180-19-003440.rtf View HTML
June 10, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003439.pdf 0001562180-19-003439.rtf View HTML
June 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003338.pdf 0001562180-19-003338.rtf View HTML
June 4, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-164605.pdf 0001193125-19-164605.rtf 0001193125-19-164605.xls View HTML
June 3, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-003224.pdf 0001562180-19-003224.rtf View HTML
May 9, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-142309.pdf 0001193125-19-142309.rtf 0001193125-19-142309.xls View HTML
May 9, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-142313.pdf 0001193125-19-142313.rtf 0001193125-19-142313.xls View HTML
May 9, 2019	3	Initial filing by director officer or owner of more than ten percent.	0001562180-19-002737.pdf 0001562180-19-002737.rtf View HTML
May 9, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-19-017969.pdf 0001564590-19-017969.rtf 0001564590-19-017969.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax